Nishan M Desilva's Net Worth

$2.58 Million

Estimate Recalculated Nov 1, 2024 03:58AM EST

Who is Nishan M Desilva?

Nishan M Desilva has an estimated net worth of $2.58 Million. This is based on reported shares across multiple companies, which include Cartesian Therapeutics, Inc., ALLOS THERAPEUTICS INC, LIGAND PHARMACEUTICALS INC, and Talon Therapeutics, Inc..

SEC CIK

Nishan M Desilva's CIK is 0001492386

Past Insider Trading and Trends

2011 was Nishan M Desilva's most active year for acquiring shares with 3 total transactions. Nishan M Desilva's most active month to acquire stocks was the month of December. 2023 was Nishan M Desilva's most active year for disposing of shares, totalling 3 transactions. Nishan M Desilva's most active month to dispose stocks was the month of October. 2011 saw Nishan M Desilva paying a total of $41,200.00 for 90,000 shares, this is the most they've acquired in one year. In 2023 Nishan M Desilva cashed out on 195,000 shares for a total of $69,750.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cartesian Therapeutics, Inc. (RNAC) Snapshot price: $14.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2,542.86%
178K
—
—
185K
Jan 2
Form 4
—
0
—
—
0
Nov 13
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 3
Form 4
∞
7K
$2.96
$20,722.80
7K
Dec 2
Form 4
—
0
—
—
0
Jun 23
Form 3
—
0
—
—
0
No matching records found

ALLOS THERAPEUTICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
35K
—
—
35K
Dec 13
Form 4
—
0
—
—
0
Jun 21
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $101.14

VP, Corporate Development

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
—
0
—
—
0
No matching records found

Talon Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jul 30
Form 3
—
0
—
—
0
No matching records found